Premenstrual Syndrome (PMS) - References
Citations
Katz VL, et al. (2007). Primary and secondary dysmenorrhea, premenstrual syndrome, and premenstrual dysphoric disorder. In LO Eckert, GM Lentz, eds., Comprehensive Gynecology, 5th ed., pp. 901-913. Philadelphia: Mosby Elsevier.
Other Works Consulted
Abajo FJ, Garcia-Rodriguez LA (2008). Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy. Archives of General Psychiatry, 65(7): 795-803.
Berga SL, Spencer JB (2009). Premenstrual syndrome. In EG Nabel, ed., ACP Medicine, section 16, chap. 3. New York: WebMD.
Davis AJ, Johnson SR (2000, reaffirmed 2008). Premenstrual syndrome. ACOG Practice Bulletin No. 15, pp. 1-9. Washington, DC: American College of Obstetricians and Gynecologists.
Kwan I, Onwude JL (2009). Premenstrual syndrome, search date July 2009. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.
Reid RL (2008). Premenstrual syndrome. In RS Gibbs et al., eds., Danforth's Obstetrics and Gynecology, 10th ed., pp. 672-681. Philadelphia: Lippincott Williams and Wilkins.
U.S. Food and Drug Administration (2005). FDA Public Health Advisory: Paroxetine. Available online: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051731.htm.
Yonkers KA, et al. (2005). Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstetrics and Gynecology, 106(3): 492-501.
WebMD Medical Reference from Healthwise
Today in PMS
Health Solutions From Our Sponsors
©2005-2012 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.